The short answer
Fenugreek may affect glucose control. Review the product before combining it with dulaglutide; the exact added low-blood-sugar risk has not been measured.
What this answer covers
Trigonella foenum-graecum seed preparations; culinary use is not a concentrated supplement.
- Supplement or preparation
- Trigonella foenum-graecum
- Medication ingredient
- dulaglutide
What the human evidence shows
A small trial adding fenugreek to metformin found no significant fall in fasting glucose. Official guidance nevertheless warns that large fenugreek doses can cause harmful low blood sugar. This does not establish a rate with the medicine here.
Why your treatment context matters
Dulaglutide particularly increases low-blood-sugar risk when combined with insulin or insulin-releasing medicines. It should not be assumed to behave like those medicines by itself. The prescriber should consider the full regimen, meals and prior low readings before deciding whether additional monitoring is useful.
Check the supplement preparation
Check the seed preparation and total daily dose. Study amounts do not define a universally safe supplement dose, and culinary exposure should not automatically inherit concentrated-product claims.
Keep the prescribed medicine plan
Continue the prescribed once-weekly injection plan. Tell the clinician about reduced eating, persistent vomiting or diarrhea and all other diabetes medicines. A supplement is not a reason to alter the injection dose yourself.
Watch for low blood sugar
Follow your existing glucose-monitoring and low-blood-sugar treatment plan. New sweating, shakiness, hunger or confusion warrants a glucose check when possible. Severe confusion, a seizure or inability to swallow safely needs emergency help.
Evidence and practical considerations
Side effects & toxicity
Conditional glucose-monitoring concern follows from supplement glucose effects and the exact medicine context. This is not direct evidence of increased hypoglycemia or altered drug absorption.
- Exact scope
- Trigonella foenum-graecum seed preparations; culinary use is not a concentrated supplement. with Exact dulaglutide once-weekly subcutaneous solution injection. Exact RxNorm IN1551291; TRULICITY subcutaneous once-weekly product, not oral semaglutide or an oral nutrient. Dose-dependent gastric emptying and concomitant medicines matter.
- Medication form and route
- subcutaneous
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact pair human interaction trial identified. Preparation-specific positive and null results do not establish a universal effect, safe dose, spacing rule or drug concentration change.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed dulaglutide.
Glucose-dependent effects, delayed gastric emptying and gastrointestinal adverse reactions; increased hypoglycemia risk with insulin or insulin secretagogues. Tested oral-drug absorption not affected to clinically relevant degree at 1.5 mg.
How this applies: Exact RxNorm IN1551291; TRULICITY subcutaneous once-weekly product, not oral semaglutide or an oral nutrient. Dose-dependent gastric emptying and concomitant medicines matter.
No universal supplement dose, interval, event rate or untested formulation equivalence.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twelve metformin-treated patients enrolled, nine completed.
Fasting glucose reduction with fenugreek was not statistically significant.
How this applies: Only the named drug, preparation, route and measured endpoints apply.
Small trial and metformin co-use; no exact requested medication exposure or adverse-event rate, not proof of universal benefit or safety.
Source 3: Federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People taking fenugreek in supplement amounts.
Large doses may cause a harmful drop in blood sugar.
How this applies: Only the original species, preparation, population and measured endpoint apply. No exact-pair clinical rate inferred.
General guidance, not a dulaglutide interaction trial or a quantified dose-response threshold.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: aa1b1e0bd7e08cb8
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.